Combination antiretroviral therapy (cART) maintains virologic control in HIV patients, but may lead to neurotoxicity. By using neuroimaging and cellular microparticle quantification, we explore the effects cART may have in both acute and chronic HIV-infection. We find that cART treatment does reduce microparticle levels associated with neuroinflammation to those of controls. Further, microparticle levels and neuroimaging results strengthen assumptions about immune dysfunction in HIV infection. We demonstrate that cerebral blood flow and cerebrovascular reactivity can be used in conjunction with quantitative microparticle levels to study the effects of neuroinflammation and cART treatment in both acute and chronic HIV infection.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords